A physical map of the CXC chemokine locus on chromosome 4 has been constructed by PCR analysis and PFGE mapping of YAC clones. The genes for IL8, GRO1, PPBP, PF4, SCYB5 (ENA-78) and SCYB6 (GCP-2) have been co-localized on a 335-kb genomic fragment. The GRO2 and GRO3 genes did not map within this region and based on analysis of a YAC contig overlapping IL8 we speculate that GRO2 and GRO3 map downstream of this region. We have also assigned the novel CXC chemokine gene, SCYB9B (alias H174/βR1) to chromosome 4q21, upstream and within 12 kb of INP10. Like INP10 and MIG, INP10 and SCYB9B are arranged in a head to tail manner. The chromosomal arrangement of these genes appears to reflect the evolution of this multigene family and supports the theory that it arose by gene duplication.

Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, Greaves DR, Zlotnik A, Schall TJ: A new class of membrane-bound chemokines with a CX3C motif. Nature 385:640–644 (1997).
Bova GS, MacGrogan D, Levy A, Pin SS, Bookstein R, Isaacs WB: Physical mapping of chromosome 8p22 markers and their homozygous deletion in a metastatic prostate cancer. Genomics 35:46–54 (1996).
Burke DT, Carle GF, Olson MV: Cloning of large segments of exogenous DNA into yeast by means of artificial chromosome vectors. Science 236:806–812 (1987).
Chang M-S, McNinch J, Basu R, Simonet S: Cloning and characterization of the human neutrophil-activating peptide (ENA-78) gene. J biol Chem 269:25277–25282 (1994).
Fan J-B, DeYoung J, Lagace R, Lina RA, Xu Z, Murray JC, Buetow KH, Weissenbach J, Goold RD, Cox DR, Myers RM: Isolation of yeast artificial chromosome clones from 54 polymorphic loci mapped with high odds on human chromosome 4. Hum Mol Genet 3:243–246 (1994).
Gunn MD, Ngo VN, Ansel KM, Ekland EH, Cyster J G, Williams LT: A B-cell-homing chemokine made in lymphoid follicles activates Burkitt’s lymphoma receptor-1. Nature 391:799–803 (1998).
Haskill S, Peace A, Morris J, Sporn SA, Anisowicz A, Lee SW, Smith T, Martin G, Ralph P, Sager R: Identification of three related human GRO genes encoding cytokine functions. Proc natl Acad Sci, USA 87:7732–7736 (1990).
Jacobs KA, Collins-Racie LA, Colbert M, Duckett M, Golden-Fleet M, Kelleher K, Kriz R, LaVallie ER, Merberg D, Spaulding V, Stover J, Williamson MJ, McCoy JM: A genetic selection for isolating cDNAs encoding secreted proteins. Gene 198:289–296 (1997).
Karrman C, Backman B, Dixon M, Holmgren G, Forsman K: Mapping of the locus for the autosomal dominant Amelogenesis Imperfecta (AIH2) to a 4-Mb YAC contig on chromosome 4q11→q21. Genomics 39:164–170 (1997).
Kelner GS, Kennedy J, Bacon KB, Kleyensteuber S, Largaespada DA, Jenkins NA, Copeland NG, Bazan JF, Moore KW, Schall TJ, Zlotnik A: Lymphotactin: a cytokine that represents a new class of chemokine. Science 266:1395–1399 (1994).
Lee HH, Farber JM: Localization of the gene for the human MIG cytokine on chromosome 4q21 adjacent to INP10 reveals a chemokine “mini-cluster”. Cytogenet Cell Genet 74:255–258 (1996).
Legler DF, Loetscher M, Roos RS, Clark-Lewis I, Baggiolini M, Moser B: B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissue, selectively attracts B lymphocytes via BLR1/CXCR5. J exp Med 187:655–660 (1998).
Luster AD, Jhanwar SC, Chaganti RS, Kersey JH, Ravetch JV: Interferon-inducible gene maps to a chromosomal band associated with a (4;11) translocation in acute leukemia cells. Proc natl Acad Sci, USA 84:2868–2871 (1987).
Modi WS, Chen Z-Q: Localization of the human CXC chemokine subfamily on the long arm of chromosome 4 using radiation hybrids. Genomics 47:136–139 (1998).
Modi WS, Dean M, Seuanez HN, Mukaida N, Matsushima K, O’Brien SJ: Monocyte-derived neutrophil chemotactic factor (MDNCF/IL8) resides in a gene cluster along with several other members of the platelet factor 4 gene superfamily. Hum Genet 84:185–187 (1990).
Rani MRS, Foster GR, Leung S, Leaman D, Stark GR, Ransohoff RM: Characterization of β-R1, a gene that is selectively induced by interferon β (IFN-β) compared with IFN-α. J biol Chem 271:22878–22884 (1996).
Richmond A, Balentien E, Thomas HG, Flaggs G, Barton DE, Spiess J, Bordoni R, Francke U, Derynck R: Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor related to b-thromboglobulin. EMBO J 7:2025–2033 (1988).
Riley JH, Ogilvie D, Anand R: Construction, characterization and screening of YAC libraries, in Anand R (ed): Techniques for the Analysis of Complex Genomes, pp 59–79 (Academic Press, London 1992).
Schuler GD, Boguski MS, Stewart EA, Stein LD, Gyapay G, Rice K, White RE, Rodriguez-Tome P, Aggarwal A, Bajorek E, Bentolila S, Birren BB, Butler A, Castle AB, Chiammilkulchai N, Chu A, Chee C, Cowles S, Day JP, Dibling T, Drouot N, Dunham I, Duprat S, East C, Hudson TJ, et al: A gene map of the human genome. Science 274:540–546 (1996).
Shirozu M, Nakano T, Inazawa J, Tashiro K, Tada H, Shinohara T, Honko T: Structure and chromosomal localization of the human stromal cell-derived factor (SDF1) gene. Genomics 28:495–500 (1995).
Smith JB, Rovai LE, Herschman HR: Sequence similarities of a subgroup of CXC chemokines related to murine LIX: implications for the interpretation of evolutionary relationships among chemokines. J Leukocyte Biol 62:598–603 (1997).
Tunnacliffe A, Majumdar S, Yan B, Poncz M: Genes for β-thromboglobulin and platelet factor 4 are closely linked and form part of a cluster of related genes on chromosome 4. Blood 79:2896–2900 (1992).
Wells TNC, Peitsch MC: The chemokine information source: identification and characterization of novel chemokines using the WorldWideWeb and Expressed Sequence Tag Databases. J Leukocyte Biol 61:545–550 (1997).
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.